PREVONCO owner Contact Information online
from NexMed (U.S.A.), Inc.
PREVONCO
US serial number:85002932
Application filling date:Mar. 31, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Jan. 27, 2014
Publication date:Apr. 26, 2011
Abandoned date:Jan. 27, 2014
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR USE IN ONCOLOGY
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 1(b)
Services:PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR USE IN ONCOLOGY
Current owner owner name:NexMed (U.S.A.), Inc.
Current owner owner address:11975 El Camino Real, Suite 300
San Diego,
CALIFORNIA
UNITED STATES
92130
Current owner legal entity type:CORPORATION
Current owner state or country:DELAWARE
Attorney name:Marc T. Morley
Attorney email:ipdocketing@foley.com
Attorney docket number:106150-7265
Attorney email authorized:Yes
Correspondent name address:Marc T. Morley
Foley & Lardner LLP
3579 Valley Centre Dr., Suite 300
San Diego,
CALIFORNIA
UNITED STATES
92130-3302
Correspondent phone:(858) 847-6700
Correspondent email:ipdocketing@foley.com
Correspondent fax:(858) 792-6773
Correspondent email authorized:Yes
Trademark staff tm attorney:POWERS, ALEXANDER L
Trademark staff law office assigned PREVONCO:LAW OFFICE 101
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (131) JOHNSON & JOHNSON (127) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (44) Wyeth LLC (41) Pfizer Inc. (39) Bristol-Myers Squibb Company (34) Forest Laboratories, Inc. (34) Vital Health Pharmaceuticals, Inc. (31) S. C. Johnson & Son, Inc. (30) Primary Investments Group Limited (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (23) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Apr. 26, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011Similar brands
